[Hypertension treatment in patients with diabetes].
Diabetic patients have an increased risk of hypertension. The coexistence of diabetes and hypertension causes higher morbidity and mortality in this population. In spite of differences between pathophysiology of hypertension in diabetes type I and type II, the antihypertensive treatment retards or prevents the appearance of overt diabetic nephropathy and reduces cardiac risk in both insulin-dependent and non-insulin-dependent diabetic subjects. Treatment of hypertension in both type I and type II diabetes comprises nonpharmacological and pharmacological interventions. Converting-enzyme inhibitors and certain calcium antagonists seems to be first line agents to preserve renal function and lower of the cardiac risk in patients with diabetes and hypertension.
Duława
J
J
Kliniki Nefrologii, Endokrynologii i Chorób Przemiany Materii Slaskiej Akademii Medycznej Katowicach.
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D003922:Diabetes Mellitus, Type 1 / Q000150:complications*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D006801:Humans; D006973:Hypertension / Q000209:etiology / Q000628:therapy*
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers
Leczenie nadciśnienia tetniczego u chorych na cukrzyce.